| [1] |
Kang TW, Lim HK, Lee MW, et al. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes[J]. Radiology, 2014, 270(3): 888-899.
|
| [2] |
范上达，邱宗祥，潘冬平．肝癌的综合治疗[J]．中华消化外科杂志, 2011, 10(4): 241-246.
|
| [3] |
Daniele A, Divella R, Quaranta M, et al. Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization[J]. Clin Biochem, 2014, 47(3): 184-190.
|
| [4] |
Finkelmeier F, Bettinger D, Köberle V, et al. Single measurement of hemoglobin predicts outcome of HCC patients[J]. Med Oncol, 2014, 31(1): 806.
|
| [5] |
郭宇，陈规划．肝细胞肝癌合并肝静脉、下腔静脉及右心房癌栓的诊断与治疗[J/CD]．中华肝脏外科手术学电子杂志，2013,2(1): 53-55.
|
| [6] |
安玉玲，张婷婷，蔡常洁．西罗莫司用于治疗肝癌肝移植术后肿瘤复发患者的疗效分析[J]．器官移植，2011, 2(2): 73-76.
|
| [7] |
Kim S, Lee J, Lee SK, et al. Protein kinase C-αdownregulates estrogen receptor-αby suppressing c-Jun phosphorylation in estrogen receptor-positive breast cancer cells[J]. Oncol Rep, 2014, 31(3): 1423-1428.
|
| [8] |
Yang Z, Zhang Y, Wang L. A feedback inhibition between miRNA-127 and TGFbeta/c-Jun cascade in HCC cell migration via MMP13[J]. PLoS One, 2013, 8(6):e65256.
|
| [9] |
Rana A, Rana B, Mishra R, et al. Mixed lineage Kinase-c-Jun N-Terminal kinase axis: a potential therapeutic target in cancer[J]. Genes Cancer, 2013, 4(9/10): 334-341.
|
| [10] |
Tinzl M, Chen B, Chen SY, et al. Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer[J]. PLoS One, 2013, 8(11): e79573.
|
| [11] |
Shao J, Teng Y, Padia R, et al. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis[J]. Neoplasia, 2013, 15(9): 1075-1085.
|
| [12] |
Eckhoff K, Flurschütz R, Trillsch F, et al. The prognostic significance of Jun transcription factors in ovarian cancer[J]. J Cancer Res Clin Oncol, 2013, 139(10): 1673-1680.
|
| [13] |
Li Z, Zhu Y, Yu M, et al. c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells[J]. Urol Oncol, 2013, 31(2): 228-233.
|
| [14] |
Yuan F, Xu Z, Yang M, et al. Overexpressed DNA polymerase iota regulated by JNK/c-Jun contributes to hypermutagenesis in bladder cancer[J]. PLoS One, 2013, 8(7): e69317.
|
| [15] |
Guo H, Xu YM, Ye ZQ, et al. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IκBα, c-Jun and androgen receptor[J]. Pharmazie, 2013, 68(6): 431-434.
|
| [16] |
Gonzalez-Villasana V, Gutiérrez-Puente Y, Tari AM. Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells[J]. Oncol Rep, 2013, 30(3): 1506-1510.
|
| [17] |
Zhang H, Yu C, Dai J, et al. Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of beta-catenin activation of the DKK1 promoter in prostate cancer[J]. Oncogene, 2014, 33(19): 2464-2477.
|
| [18] |
Cao Z, Zhang R, Li J, et al. X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis[J]. J Biol Chem, 2013, 288(28): 20238-20247.
|
| [19] |
Hu L, Xia L, Zhou H, et al. TF/FVⅡa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620[J]. Tumour Biol, 2013, 34(5): 2573-2581.
|